| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $361.1M | +21.8% |
| R&D Expense | $57.3M | +41.1% |
| SG&A Expense | $86.2M | +12.7% |
| Operating Income | -$85.8M | -108.8% |
| Pre-tax Income | -$76.6M | -110.3% |
| Income Tax | -$2.2M | -1760.2% |
| Net Income | -$74.4M | -103.5% |
| EPS (Basic) | -$1.02 | -100.0% |
| EPS (Diluted) | -$1.02 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $216.5M | +40.3% |
| Accounts Receivable | $40.4M | -8.3% |
| Inventory | $16.1M | +12.8% |
| Current Assets | $285.6M | +14.9% |
| Total Assets | $1.11B | -3.6% |
| Current Liabilities | $61.2M | -2.2% |
| Total Liabilities | $70.8M | -12.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $44.2M | +486.9% |
| Capital Expenditures | $10.0M | +16.5% |
| Investing Cash Flow | $15.1M | +151.4% |
| Financing Cash Flow | $2.8M | -18.8% |
| Free Cash Flow | $34.3M | +3478.8% |
| -100.0% |
| Stockholders' Equity |
| $1.04B |
| -2.9% |